Large-scale testing (Phase 3)WithdrawnNCT01837927
What this trial is testing
Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.
Who this might be right for
Pulmonary Disease, Chronic Obstructive
Novartis Pharmaceuticals